Legal Representation
Attorney
Matthew P. Frederick
USPTO Deadlines
Next Deadline
131 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
November 21, 2025
Extension Available
Until November 21, 2024
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| May 22, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 21, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED |
| May 21, 2025 | EXT3 | S | SOU EXTENSION 3 FILED |
| May 21, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 21, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Nov 21, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Nov 21, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 21, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| May 21, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 21, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 26, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 26, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 6, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 21, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 8, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 7, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 7, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 5, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| May 5, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| May 5, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| May 4, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 14, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Apr 13, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 24, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medical diagnostic reagents and assays for testing bodily fluids; diagnostic testing kits comprised of diagnostic reagents, assays and specimen holders for testing of bodily fluids for use in disease detection, diagnosing, monitoring, reporting, treating, and prevention, namely, neurodegenerative diseases and neurological diseases
Class 044
Medical testing for diagnostic or treatment purposes; medical laboratory, diagnostic testing, monitoring and reporting services; medical testing for disease, illness, and pathology tracking, treating, and prevention purposes
Additional Information
Design Mark
The mark consists of a circle made up of various sized full circles to the left of the PrecivityAD2.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PRECIVITY AD TWO
Classification
International Classes
005
044
USPTO Documents
Loading USPTO documents...